Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Frankel

Showing results (261-270 of 359) with videos related to

Pageof 36
Sort By:
JAMA Neurology|May 24, 2013
Comparison of final infarct volumes in patients who received endovascular therapy or intravenous thrombolysis for acute intracranial large-vessel occlusionsSrikant Rangaraju, Kumiko Owada, Ali Reza Noorian, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Biological Psychiatry|July 1, 1990
Evidence against close linkage of unipolar affective illness to human chromosome 11p markers HRAS1 and INS and chromosome Xq marker DXS52K Neiswanger, S A Slaugenhaupt, H B Hughes, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Clinical Outcomes in Basal Ganglia Strokes Treated With Mechanical ThrombectomyMehdi Bouslama, Diogo C Haussen, Krishnan Ravindran, et al.
Interventional Neurology|April 10, 2018
Clinical and Imaging Outcomes of Endovascular Therapy in Patients with Acute Large Vessel Occlusion Stroke and Mild Clinical SymptomsMeredith T Bowen, Leticia C Rebello, Mehdi Bouslama, et al.
Cancer|September 5, 2002
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemiaMark A Weiss, Timothy B Aliff, Martin S Tallman, et al.
Blood|September 9, 2006
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Madeleine Duvic, Rakshandra Talpur, Xiao Ni, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 11, 2007
Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic strokeKevin M Barrett, Thomas G Brott, Robert D Brown, et al.
Journal of Immune Based Therapies and Vaccines|January 20, 2011
Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIVJames B Whitney, Saied Mirshahidi, So-Yon Lim, et al.
Journal of Neurointerventional Surgery|August 4, 2017
Thrombectomy versus medical management for large vessel occlusion strokes with minimal symptoms: an analysis from STOPStroke and GESTOR cohortsDiogo C Haussen, Fabricio O Lima, Mehdi Bouslama, et al.
Pageof 36

Showing results (261-270 of 359) with videos related to

Sort By:
Pageof 36
JAMA Neurology|May 24, 2013
Comparison of final infarct volumes in patients who received endovascular therapy or intravenous thrombolysis for acute intracranial large-vessel occlusionsSrikant Rangaraju, Kumiko Owada, Ali Reza Noorian, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Biological Psychiatry|July 1, 1990
Evidence against close linkage of unipolar affective illness to human chromosome 11p markers HRAS1 and INS and chromosome Xq marker DXS52K Neiswanger, S A Slaugenhaupt, H B Hughes, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Clinical Outcomes in Basal Ganglia Strokes Treated With Mechanical ThrombectomyMehdi Bouslama, Diogo C Haussen, Krishnan Ravindran, et al.
Interventional Neurology|April 10, 2018
Clinical and Imaging Outcomes of Endovascular Therapy in Patients with Acute Large Vessel Occlusion Stroke and Mild Clinical SymptomsMeredith T Bowen, Leticia C Rebello, Mehdi Bouslama, et al.
Cancer|September 5, 2002
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemiaMark A Weiss, Timothy B Aliff, Martin S Tallman, et al.
Blood|September 9, 2006
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Madeleine Duvic, Rakshandra Talpur, Xiao Ni, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 11, 2007
Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic strokeKevin M Barrett, Thomas G Brott, Robert D Brown, et al.
Journal of Immune Based Therapies and Vaccines|January 20, 2011
Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIVJames B Whitney, Saied Mirshahidi, So-Yon Lim, et al.
Journal of Neurointerventional Surgery|August 4, 2017
Thrombectomy versus medical management for large vessel occlusion strokes with minimal symptoms: an analysis from STOPStroke and GESTOR cohortsDiogo C Haussen, Fabricio O Lima, Mehdi Bouslama, et al.
Pageof 36